Literature DB >> 18079228

Lung allocation score for lung transplantation: impact on disease severity and survival.

Cynthia J Gries1, Michael S Mulligan, Jeffrey D Edelman, Ganesh Raghu, J Randall Curtis, Christopher H Goss.   

Abstract

BACKGROUND: Prior to implementation of the lung allocation score (LAS) system, allocation of donor lungs was based on accrued time on the waiting list and was potentially influenced by center-specific thresholds for listing. The impact of LAS implementation on patient characteristics and survival is unknown.
METHODS: United Network of Organ Sharing data were obtained on all lung transplant candidates listed and all patients undergoing transplantation in region 6 between May 4, 2003, and May 4, 2006. Each data set was divided into two cohorts: 2 years before LAS implementation, and 1 year after LAS implementation. LAS was calculated and compared by cohort. Pre-LAS and post-LAS differences in patient characteristics were examined. Waiting list and posttransplant survival rates for each cohort were examined using Kaplan-Meier estimates and Cox regression.
RESULTS: After LAS implementation, the distribution of diagnoses in patients undergoing transplantation significantly changed (p = 0.02), while the distribution of diagnoses in those listed did not (p = 0.17). Characteristics of patients on the waiting list were similar, except that a higher proportion of nonwhite patients were listed (p = 0.04) and lower FVC (p < 0.001) was observed after LAS implementation. Similarly, characteristics of patients undergoing transplantation did not change, except that posttransplant hospital length of stay was shorter (p = 0.01) after LAS implementation. Calculated LAS was higher after LAS implementation (p = 0.006). After controlling for age and diagnosis, neither waiting list nor transplant survival was significantly different (p = 0.93 and p = 0.81, respectively).
CONCLUSIONS: After LAS implementation, the distribution of diagnoses in lung transplant recipients was significantly changed, while that of candidates was not. Posttransplant and waiting list survival were not affected by the LAS system, but power was limited. Larger and long-term survival studies are needed to determine if the LAS system improves overall allocation and survival for patients interested in lung transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 18079228     DOI: 10.1378/chest.07-1160

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  High lung allocation score is associated with increased morbidity and mortality following transplantation.

Authors:  Mark J Russo; Alexander Iribarne; Kimberly N Hong; Ryan R Davies; Steve Xydas; Hiroo Takayama; Ali Ibrahimiye; Annetine C Gelijns; Matthew D Bacchetta; Frank D'Ovidio; Selim Arcasoy; Joshua R Sonett
Journal:  Chest       Date:  2009-10-09       Impact factor: 9.410

2.  Increased resource use in lung transplant admissions in the lung allocation score era.

Authors:  Bryan G Maxwell; Joshua J Mooney; Peter H U Lee; Joseph E Levitt; Laveena Chhatwani; Mark R Nicolls; Martin R Zamora; Vincent Valentine; David Weill; Gundeep S Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

3.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

4.  Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States - a retrospective study.

Authors:  Jeremiah William Awori Hayanga; Heather K Hayanga; James H Fugett; Kelsey A Musgrove; Ghulam Abbas; Christopher R Ensor; Vinay Badhwar; Norihisa Shigemura
Journal:  Transpl Int       Date:  2020-05-12       Impact factor: 3.782

5.  Disparities in lung transplantation before and after introduction of the lung allocation score.

Authors:  Keith M Wille; Kathy F Harrington; Joao A deAndrade; Sonia Vishin; Robert A Oster; Richard A Kaslow
Journal:  J Heart Lung Transplant       Date:  2013-04-09       Impact factor: 10.247

6.  Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients.

Authors:  Andrew T Braun; Elliott C Dasenbrook; Ashish S Shah; Jonathan B Orens; Christian A Merlo
Journal:  J Heart Lung Transplant       Date:  2015-06-11       Impact factor: 10.247

Review 7.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

8.  Impact of the lung allocation score on survival beyond 1 year.

Authors:  B G Maxwell; J E Levitt; B A Goldstein; J J Mooney; M R Nicolls; M Zamora; V Valentine; D Weill; G S Dhillon
Journal:  Am J Transplant       Date:  2014-09-10       Impact factor: 8.086

9.  Utilization and Cost Analysis of Lung Transplantation and Survival After 10 Years of Adapting the Lung Allocation Score.

Authors:  Cesar A Keller; Thomas A Gonwa; Launia J White; March E Rucci; Sue L Visscher; Cassie C Kennedy; Richard C Daly; James M Naessens
Journal:  Transplantation       Date:  2019-03       Impact factor: 4.939

10.  The lung allocation score and survival in lung transplant candidates with chronic obstructive pulmonary disease.

Authors:  David R Nunley; Gerene S Bauldoff; Christopher H Holloman; Amy Pope-Harman
Journal:  Lung       Date:  2009-10-06       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.